<prompt> Which of the following is an anti - VEGF drug?AdalimumabBevacizumabCetuximabDaclizumab  <response>: Ans. is b i.e., Bevacizumab Monoclonal AntibodyTargetIndicationTrastuzumabher-2neuBreast cancerTositumomabCD 20B-cell NHLRituximabCD 20B-cell NHLlbritumomabCD 20B-cell NHLDaclizumabIL-2R CD-25ImmunosuppressantBasiliximabIL-2R CD-25I mmunosuppressantAbciximabGpIIIIIaAntiplateletPalivizumabFusion proteinRSVInfliximabTNF aRA,Crohns diseaseEtanerceptTNF aRA rheumatoid arthritisOfatumumabCD 20SLEBelimumabBLySSLEEpratuzumabCD 22SLEOcrelizumabCD 20SLEAdalimumabTNF aRAAlefaceptLFA-3Plaque psoriasisAlemtuzumabCD 52B cell CLLBevacizumabVEGFColorectal carcinomaCetuximabEGFRColorectal carcinomaGemtuzumabCD 33AMLEfalizumabCD 1 la chain of LFAPsoriasisOmalizumabIgEBronchial asthmaNatalizumabIntegrin-a4Multiple sclerosisDonesumabRANK ligandOsteoporosisTocilizumabIL-6RSLEPanitumumabEGFRColorectal carcinomaRanibizomabVEGFNeovascular macular degenerationNimotuzumabEGFRSquamous cell carcinoma, gliomaEculizumabC5 complement componentParoxysomal nocturnal hemoglobinuria 